Stilla is exhibiting at the 10th CNAPS in Montpellier
20th-22nd of September 2017, Montpellier (France)
CNAPS International Symposium – Recent Advances in Circulating DNA & RNA
20th-22nd of September 2017
From the 20th to the 22nd of September, Stilla Technologies, represented by Caroline Charky (Director of Business Development), Alexandra Martin (Sales Application Specialist) and Sarah Jemai (Marketing Manager), has attended the 10th CNAPS International Symposium (Recent Advances in Circulating DNA & RNA) which took place in Montpellier, France.
This International Symposium was organized by Alain Thierry (Institute of Cancer Research, Montpellier), Safia el Messaoudi and Sabine Dejasse and highlights how circulating nucleic acids became an important part of medical diagnosis in particularly in the oncology and NIPT field.
For 3 days, more than 200 participants had the chance to assist to keynote lectures as well as industrial communications about the structure, the detection and the biological functions of circulating nucleic acids.
Using body fluids like serum and plasma; worldwide teams have presented their studies around the cfDNA field: tumor-derived variants, DNA methylation, treatment monitoring etc.
This symposium aimed to spotlight circulating acids scope of applications in gene expression, in liquid biopsies, in clinical practices and many others.
Whether analyzing cell-free fetal DNA or maternal plasma, non-invasive prenatal testing (NIPT) became a key topic in the circulating nucleic acid field, offering an alternative way for studying fetal genomics.
It was interesting for Stilla Technologies to meet researchers with applications where digital PCR can be useful. Indeed, Stilla’s team was happy to advise and answer questions on the two key fields that are oncology and NIPT, showing the Naica System workflow live!